Your browser doesn't support javascript.
loading
TRPS1 Is a Lineage-Specific Transcriptional Dependency in Breast Cancer.
Witwicki, Robert M; Ekram, Muhammad B; Qiu, Xintao; Janiszewska, Michalina; Shu, Shaokun; Kwon, Mijung; Trinh, Anne; Frias, Elizabeth; Ramadan, Nadire; Hoffman, Greg; Yu, Kristine; Xie, Yingtian; McAllister, Gregory; McDonald, Rob; Golji, Javad; Schlabach, Michael; deWeck, Antoine; Keen, Nicholas; Chan, Ho Man; Ruddy, David; Rejtar, Tomas; Sovath, Sosathya; Silver, Serena; Sellers, William R; Jagani, Zainab; Hogarty, Michael D; Roberts, Charles; Brown, Myles; Stegmaier, Kimberly; Long, Henry; Shivdasani, Ramesh A; Pellman, David; Polyak, Kornelia.
Afiliação
  • Witwicki RM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA.
  • Ekram MB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA.
  • Qiu X; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Janiszewska M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA.
  • Shu S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA.
  • Kwon M; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Pediatrics, Harvard Medical School, Boston, MA 02115, USA.
  • Trinh A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA.
  • Frias E; Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA.
  • Ramadan N; Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA.
  • Hoffman G; Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA.
  • Yu K; Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA.
  • Xie Y; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • McAllister G; Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA.
  • McDonald R; Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA.
  • Golji J; Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA.
  • Schlabach M; Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA.
  • deWeck A; Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA.
  • Keen N; Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA.
  • Chan HM; Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA.
  • Ruddy D; Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA.
  • Rejtar T; Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA.
  • Sovath S; Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA.
  • Silver S; Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA.
  • Sellers WR; Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA.
  • Jagani Z; Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA.
  • Hogarty MD; Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
  • Roberts C; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Pediatrics, Harvard Medical School, Boston, MA 02115, USA.
  • Brown M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Stegmaier K; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Pediatrics, Harvard Medical School, Boston, MA 02115, USA.
  • Long H; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Shivdasani RA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Pellman D; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Pediatrics, Harvard Medical School, Boston, MA 02115, USA.
  • Polyak K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA. Electronic address: kornelia_polyak@dfci.harvard.
Cell Rep ; 25(5): 1255-1267.e5, 2018 10 30.
Article em En | MEDLINE | ID: mdl-30380416
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Fatores de Transcrição / Transcrição Gênica / Neoplasias da Mama / Linhagem da Célula / Proteínas de Ligação a DNA Limite: Female / Humans Idioma: En Revista: Cell Rep Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Fatores de Transcrição / Transcrição Gênica / Neoplasias da Mama / Linhagem da Célula / Proteínas de Ligação a DNA Limite: Female / Humans Idioma: En Revista: Cell Rep Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos